Rajshree Sugars (RAJSREESUG)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price ₹35.18 vs book value ₹84.76 gives a 58% discount to book (P/B 0.42).
• Piotroski F-Score 7/9 suggests improving fundamentals despite the current loss.
• Sales grew 20.69%, and ROCE is positive at 4.42%.
• Promoter holding at 40.72% provides some insider alignment.

Concerns

• Latest quarter net loss of ₹9 Cr on sales of ₹98 Cr; ROE -6.62% shows book value is not earning its keep.
• Debt/equity of 1.38 is high and dividend yield is zero, so risk is not compensated while waiting.
• Commodity sugar business lacks pricing power and a durable moat; earnings are cyclical.
• Profit growth of 62.82% is unreliable because the latest quarter is still loss-making.

AI Analysis

When I look at Rajshree Sugars, my Graham instinct is to start with the balance sheet. The stock sells at ₹35.18 while book value is ₹84.76—only 0.42 times book. That is a real margin of safety if those assets are worth their stated value. But the income statement does not yet cooperate. The latest quarter shows sales of ₹98 Cr and a net loss of ₹9 Cr; return on equity is -6.62%. Sugar is a commodity business, so the company has little pricing power and no durable moat. Debt/equity of 1.38 makes the position more uncomfortable, and with zero dividend, I get nothing while waiting. Sales growth of 20.69% is encouraging, and ROCE of 4.42% shows that operations are generating some return above nothing. The Piotroski F-Score of 7/9 is also a positive signal—it suggests the financial health is improving, despite the loss. As for the reported profit growth of 62.82%, I would not rely on it; with a current quarterly loss, that number likely comes from a weak base and could be misleading. Promoter holding of 40.72% gives some alignment, but it does not create an economic moat. The 52-week range of ₹24.65 to ₹49.70 shows the share is in the lower half of its range, but that alone is not a reason to buy. This is a cyclical, asset-backed situation, not a wonderful compounder. I would only consider it if the sugar cycle turns and quarterly losses narrow. Until I see evidence that the balance sheet is deleveraging and earnings power is returning, the cheap price is a possible value trap.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer